Successful infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in two Taiwanese children: An experience from a medical center
Saved in:
| Main Authors: | Chun-Ting Liu, G.W. Gant Luxton, Chia-Cheng Sung, Fu-Min Wang, Chia-Ning Chang, Chih-Fen Hu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-05-01
|
| Series: | Pediatrics and Neonatology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1875957223002231 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Infliximab in treatment of refractory multisystem inflammatory syndrome in children with severe cardiac dysfunction
by: Guruprasad Hassan Shankar, et al.
Published: (2022-01-01) -
Successful Long-Term Use of Infliximab in Refractory Pouchitis in an Adolescent
by: Jessica Yeates, et al.
Published: (2010-01-01) -
Successful Discontinuation of Infliximab in a Refractory Case of Vasculo-Behçet Disease
by: Akihiro Nakamura, et al.
Published: (2016-01-01) -
Identification of a novel NF1 deletion variant in a Taiwanese boy with neurofibromatosis type 1-associated Moyamoya syndrome
by: Yung-Yu Yang, et al.
Published: (2023-03-01) -
Infliximab for Idiopathic Deep Cutaneous Vasculitis Refractory to Cyclophosphamide
by: Marcelo Derbli Schafranski, et al.
Published: (2010-01-01)